, Geneva: World Health Organization, WHO. Yellow fever fact sheet, 2019.

T. P. Monath and P. F. Vasconcelos, Yellow fever, J Clin Virol, vol.64, pp.160-73, 2015.

T. Garske, M. D. Van-kerkhove, and S. Yactayo, Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data, PLoS Med, vol.11, p.1001638, 2014.

F. M. Shearer, C. L. Moyes, and D. M. Pigott, Global yellow fever vaccination coverage from 1970 to 2016: an adjusted retrospective analysis, Lancet Infect Dis, vol.17, pp.1209-1226, 2017.

, Vaccines and vaccination against yellow fever: WHO position paper, Vaccine, vol.33, pp.76-77, 2013.

I. J. Amanna and M. K. Slifka, Questions regarding the safety and duration of immunity following live yellow fever vaccination, Expert Rev Vaccines, vol.15, pp.1519-1552, 2016.

, Collaborative Group for Studies of Yellow Fever Vaccination. A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old, Mem Inst Oswaldo Cruz, vol.110, pp.771-80, 2015.

M. J. Hepburn, M. G. Kortepeter, and P. R. Pittman, Neutralizing antibody response to booster vaccination with the 17D yellow fever vaccine, Vaccine, vol.24, pp.2843-2892, 2006.

T. P. Monath, M. S. Cetron, and K. Mccarthy, Yellow fever 17D vaccine safety and immunogenicity in the elderly, Hum Vaccin, vol.1, pp.207-221, 2005.

R. De-menezes-martins, M. Maia, and S. De-lima, Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study, Vaccine, vol.36, pp.4112-4129, 2018.

R. W. Wieten, A. Goorhuis, and E. Jonker, 17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients, J Infect, vol.72, pp.713-735, 2016.

A. C. Campi-azevedo, P. De-almeida-estevam, and J. G. Coelho-dos-reis, Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline, BMC Infect Dis, vol.14, p.391, 2014.

S. Lydersen, M. W. Fagerland, and P. Laake, Recommended tests for association in 2×2 tables, Stat Med, vol.28, pp.1159-75, 2009.

G. D. Ruxton and M. Neuhäuser, Improving the reporting of P-values generated by randomization methods, Methods Ecol Evol, vol.4, pp.1033-1069, 2013.

R. Chowdhury, P. Meier, C. Laraway, and H. , Immunogenicity of yellow fever vaccine coadministered with MenAfriVac in healthy infants in Ghana and Mali, Clin Infect Dis, vol.61, issue.5, pp.586-93, 2015.

, Geneva: World Health Organization, WHO. International health regulations, 2005.

E. Gotuzzo, S. Yactayo, and E. Cordova, Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years, Am J Trop Med Hyg, vol.89, pp.434-478, 2013.

J. E. Staples, J. A. Bocchini, L. Rubin, and M. Fischer, Yellow fever vaccine booster doses: recommendations of the Advisory Committee on Immunization Practices, MMWR Morb Mortal Wkly Rep, vol.64, pp.647-50, 2015.

C. F. Estofolete and M. L. Nogueira, Is a dose of 17D vaccine in the current context of yellow fever enough?, Braz J Microbiol, vol.49, pp.683-84, 2018.

P. F. Vasconcelos, Single shot of 17D vaccine may not confer life-long protection against yellow fever, Mem Inst Oswaldo Cruz, vol.113, pp.135-172, 2018.

M. P. Grobusch, M. Van-aalst, and A. Goorhuis, Yellow fever vaccinationonce in a lifetime, Travel Med Infect Dis, vol.15, pp.1-2, 2017.

D. Patel and H. Simons, Yellow fever vaccination: is one dose always enough, Travel Med Infect Dis, vol.11, pp.266-73, 2013.

, Grading of recommendations, assessment, development, and evaluation (GRADE) for yellow fever vaccine booster doses, Centers for Disease Control and Prevention, 2015.

, Eliminate yellow fever epidemics (EYE): a global strategy, Wkly Epidemiol Rec, vol.92, pp.193-204, 2017.

A. M. Watson, L. K. Lam, W. B. Klimstra, and K. D. Ryman, The 17D-204 vaccine strain-induced protection against virulent yellow fever virus is mediated by humoral immunity and CD4+ but not CD8+ T cells, PLoS Pathog, vol.12, p.1005786, 2016.

A. C. Campi-azevedo, C. Costa-pereira, and L. R. Antonelli, Booster dose after 10 years is recommended following 17DD-YF primary vaccination, Hum Vacc Immunother, vol.12, pp.491-502, 2016.

,

E. Muyanja, A. Ssemaganda, and P. Ngauv, Immune activation alters cellular and humoral responses to yellow fever 17D vaccine, J Clin Invest, vol.124, pp.3147-58, 2014.

. Ifrc and . Ghana, Yellow fever outbreak. DREF operation n° MDRGH005. International Federation of Red Cross and Red Crescent Societies, 2012.

T. P. Monath and A. D. Barrett, Pathogenesis and pathophysiology of yellow fever, Adv Virus Res, vol.60, pp.343-95, 2003.

M. Kongsgaard, M. R. Bassi, and M. Rasmussen, Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination, Sci Rep, vol.7, p.662, 2017.

M. Lhuillier, M. J. Mazzariol, and S. Zadi, Study of combined vaccination against yellow fever and measles in infants from six to nine months, J Biol Stand, vol.17, pp.9-15, 1989.

I. Stefano, H. K. Sato, and C. S. Pannuti, Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine, Vaccine, vol.17, pp.1042-1048, 1999.

J. D. Poland, C. H. Calisher, T. P. Monath, W. G. Downs, and K. Murphy, Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine, Bull World Health Organ, vol.59, pp.895-900, 1981.

C. Goujon, M. L. Gougeon, and L. Tondeur, CHRONOVAC VOYAGEUR: a study of the immune response to yellow fever vaccine among infants previously immunized against measles, Vaccine, vol.35, pp.6166-71, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01702891

N. Silva, J. R. Camacho, L. A. Siqueira, and M. M. , Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella, Vaccine, vol.29, pp.6327-6361, 2011.

R. Michel, F. Berger, and J. Ravelonarivo, Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?, Vaccine, vol.33, pp.2301-2307, 2015.

J. Lang, J. Zuckerman, P. Clarke, P. Barrett, C. Kirkpatrick et al., Comparison of the immunogenicity and safety of two 17D yellow fever vaccines, Am J Trop Med Hyg, vol.60, pp.1045-50, 1999.

T. P. Monath, R. Nichols, and W. T. Archambault, Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial, Am J Trop Med Hyg, vol.66, pp.533-574, 2002.

S. E. Moore, A. C. Collinson, and A. J. Fulford, Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan, Trop Med Int Health, vol.11, pp.1529-1570, 2006.

. Psatt-004, Ghana. ISRCTN registry number ISRCTN82484612

, double-blind, randomised, controlled, dose ranging study to evaluate the safety, immunogenicity, dose response and schedule response of a meningococcal A conjugate vaccine administered concomitantly with local expanded program on immunisation (EPI) vaccines in healthy infants. 2. Pers-007 (phase IV), Ghana. ISRCTN registry number ISRCTN10763234

, Evaluation of antibody persistence in Ghanaian children more than five years after vaccination with MenAfriVac ® widely used in Sub-Saharan Africa to prevent epidemic meningitis

. Psatt-007, Mali. Pan African Clinical Trials Registry number PACTR201110000328305 URL

I. Phase, double-blind, randomized, controlled study to evaluate the immunogenicity and safety of different schedules and formulations of a meningococcal A conjugate vaccine administered concomitantly with local EPI vaccines in healthy infants and toddlers

, Pers-007 (phase IV), Mali. ISRCTN registry number ISRCTN37623829 URL

, Long-term follow-up of children who participated at 9-12 months of age in clinical trial PsA-TT-007 in Mali

P. Good, Permutation tests: a practical guide to resampling methods for testing hypotheses, 2000.

G. D. Ruxton and M. Neuhäuser, Improving the reporting of P-values generated by randomization methods, Methods Ecol Evol, vol.4, pp.1033-1039, 2013.